Pharmacokinetics of remikiren, a potent orally active inhibitor of human renin, in rat, dog and primates

Xenobiotica

Volumn 26, Issue 3, 1996, Pages 333-345

  Coassolo, Ph ^a   Fischli, W ^a   Clozel, J P ^a   Chou, R C ^a  

^a F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

REMIKIREN; RENIN INHIBITOR;

ANIMAL EXPERIMENT; ARTICLE; BILIARY EXCRETION; CONTROLLED STUDY; DOG; DRUG BLOOD LEVEL; DRUG EXCRETION; DRUG METABOLISM; DRUG TOLERANCE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INTRAVENOUS DRUG ADMINISTRATION; MONKEY; NONHUMAN; ORAL DRUG ADMINISTRATION; PHARMACOKINETICS; RAT; SPECIES DIFFERENCE;

ANIMALIA; CANIS FAMILIARIS; PRIMATES;

EID: 0029929451     PISSN: 00498254     EISSN: None     Source Type: Journal    
DOI: 10.3109/00498259609046712     Document Type: Article

References (20)

1. BOXENBAUM, H., 1980, Interspecies variation in liver weight, hepatic blood flow, and antipyrine intrinsic clearance: extrapolation of data to benzodiazepines and phenitoine. Journal of Pharmacology and Biopharmacology, 8, 165-176.
2. BRUNO, G. A., and CHRISTIAN, J. K., 1961, Determination of 14C in aqueous bicarbonate solutions by liquid scintillation counting. Annals of Chemistry, 33, 1216-1218,
3. CLOZEL, J-P., and FISCHLI, W., 1993, Comparative effects of three different potent renin inhibitors in primates. Hypertension, 22, 9-17.
4. EDWARDS, C. R. W., and PADFIELD, P. L., 1985, Angiotensin-converting enzyme inhibitors : past, present and bright future. Lancet, 1, 30-34.
5. ERDÖS, E. G., 1975, Angiotensin I converting enzyme. Circulation Research, 36, 247-255.
6. FISCHLI, W., CLOZEL, J-P., EL AMRANI, K., WOSTL, W., NEIDHART, W., STADLER, H., and BRANCA, Q., 1991, Ro 42-5892 is a potent orally active renin inhibitor in primates. Hypertension, 18, 22-31.
7. HARDUF, Z., NIR, T., and JUVEN, B. J., 1988, High performance liquid Chromatography of biogenic amines, derivatized with 9-fluorenylmethyl chloroformate. Journal of Chromatography, 437, 379-386.
8. KLEINBLŒEM, C. H., WEBER, C., FAHRNER, E., DELLENBACH, M., WELKER, H., SCHRÖTER, V., and BELZ, G. G., 1993, Hemodynamics, biochemical effects and pharmacokinetics of the renin inhibitor remikiren in healthy human subjects. Clinical Pharmacology and Therapeutics, 53, 585-592.
9. KOBRIN, I., VISKOPER, R. J., LASZT, A., BOCK, J., WEBER, C., and CHARLON, V., 1993, Effects of an orally active renin inhibitor, Ro 42-5892, in patients with essential hypertension. American Journal of Hypertension, 6, 349-356.
10. KOKUBU, T., and HIWADA, K., 1987, Human renin inhibitors. Drugs Today, 23, 101-108.
11. LINDGREN, B. R., and ANDERSSON, R. G. G., 1989, Angiotensin-converting enzyme inhibitors and their influence on inflammation, bronchial reactivity and cough. Medical Toxicology and Adverse Drug Experiments, 4, 369-380.
12. LUTZ, R. J., DERRICK R. L., TUEY, D., SIPES, M. W., ANDERSON, H. B., and MATHEWS, H. B., 1984, Comparison of the pharmacokinetics of several polychlorinated biphenyls in mouse, rat, dog and monkey by means of a physiological pharmacokinetic model. Drug Metabolism and Disposition, 12, 527-535.
13. OHNHAUS, E. E., and LOCHER, J. T., 1975, Liver blood flow and blood volume following chronic phenobarbitone administration. European Journal of Pharmacology, 31, 161-165.
14. RONGEN, G. A., LENDERS, J. W. M., KLEINBLŒSEM, C. H., WEBER, C., WELKER, H., FAHRNER, E., POZENEL, H., WOITTIEZ, A-J. J., HAUG, G., BUCHMANN, M. S., HÖGLUND, C. E. K., and THIEN, T., 1993, Efficacy and tolerability of the renin inhibitor Ro 42-5892 in patients with hypertension. Clinical Pharmacology and Therapeutics, 54, 567-577.
15. SATO, T., 1987, New method for measurement of hepatic blood flow in the rat using thermodilution method. Circulation Shock, 21, 31-37.
16. SHAH, A. J., and ADLARD, M. W., 1988, Determination of β-lactams and their biosynthetic intermediates in fermentation media by pre-column derivatisation followed by fluorescence detection. Journal of Chromatography, 424, 325-336.
17. VAN DEN MEIRACKER, A. H., ADMIRRAL, P. J. J., MAN IN'T VELD, A. J., DERKX, F. H. M., VAN ECK, H. J. R., MULDER, P., and SCHALEKAMP, M. A. D. H., 1990, Prolonged blood pressure reduction by orally active renin inhibitor Ro 42-5892 in essential hypertension. British Medical Journal, 301, 205-210.
18. VISKOPER, R. J., CHARLON, V., LASZT, A., YOSEFY, C., BOCK, J., LANDAU, M., and KOBRIN, I., 1994, Time dependency of the antihypertensive efficacy of the new renin inhibitor Ro 42-5892. Journal of Hypertension, 8, 133-136.
19. WAEBER, B., NUSSBERGER, J., and BRUNNER, H. R., 1986, The renin-angiotensin system: role in experimental and human hypertension. In Handbook of Hypertension, edited by W. H. Birkenhaeger and J. L. Reid (Elsevier: Amsterdam), 8, 489-519.
20. WEBER, C., BIRNBÖCK, H., LEUBE, J., KOBRIN, I., KLEINBLŒSEM, C. H., and VAN BRUMMELEN, P., 1993, Multiple dose pharmacokinetics and concentration effect relationship of the orally active renin inhibitor remikiren (Ro 42-5892) in hypertensive patients. British Journal of Clinical Pharmacology, 36, 547-554.